NCT07474480

Brief Summary

This prospective, single-center observational study compares the effects of general anesthesia and spinal anesthesia on tissue perfusion in patients undergoing lower extremity surgery with tourniquet use. Tissue oxygenation in the limb distal to the tourniquet is monitored noninvasively using near-infrared spectroscopy (NIRS), and perfusion loss is quantified using an area-under-the-curve (AUC) approach. The primary objective is to evaluate whether spinal anesthesia better preserves distal tissue oxygenation during tourniquet inflation compared with general anesthesia. Secondary objectives are to assess reperfusion response after tourniquet release using changes in NIRS values at 20 minutes relative to baseline, the presence of early hyperemia (rSO₂ overshoot), and the association between tourniquet duration and perfusion loss. Additional exploratory analyses evaluate selected metabolic and inflammatory markers, including pH, lactate, and potassium.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 25, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 12, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 11, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 16, 2026

Completed
Last Updated

May 28, 2026

Status Verified

March 1, 2026

Enrollment Period

6 months

First QC Date

March 11, 2026

Last Update Submit

May 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage AUC Loss During Tourniquet Inflation

    Distal tissue oxygenation/perfusion loss measured by near-infrared spectroscopy (NIRS) as the percentage area-under-the-curve (AUC) loss of regional tissue oxygen saturation (rSO₂) during tourniquet inflation.

    From tourniquet inflation to tourniquet deflation during surgery

Secondary Outcomes (3)

  • Reperfusion Response Assessed by ΔNIRS

    Baseline to 20 minutes after tourniquet deflation

  • Early Hyperemia (rSO₂ Overshoot)

    Within 5 minutes after tourniquet deflation

  • Association Between Tourniquet Duration and Percentage AUC Loss

    Intraoperative period, during tourniquet use

Other Outcomes (1)

  • Metabolic and Inflammatory Markers

    Perioperative period

Study Arms (2)

General Anesthesia Group

Patients undergoing lower extremity surgery under general anesthesia.

Spinal Anesthesia Group

Patients undergoing lower extremity surgery under spinal anesthesia.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults aged 18 to 65 years with ASA physical status I-II who were scheduled for elective lower extremity orthopedic surgery with tourniquet use at Prof. Dr. Cemil Taşcıoğlu City Hospital between 01 March 2025 and 30 September 2025. Eligible patients were assessed consecutively and enrolled after providing informed consent. Patients were analyzed in 2 observational cohorts according to anesthesia method used in routine clinical practice: general anesthesia and spinal anesthesia.

You may qualify if:

  • Age 18 to 65 years
  • Scheduled for elective lower extremity orthopedic surgery
  • ASA physical status I or II
  • Expected operation duration 30 to 120 minutes
  • Expected tourniquet duration 30 to 90 minutes
  • Informed about the anesthesia method and agreed to participate voluntarily
  • No contraindication to neuraxial block

You may not qualify if:

  • Refusal to participate
  • History of peripheral arterial disease, diabetic neuropathy, or advanced vascular insufficiency
  • Severe or uncontrolled systemic disease, including ASA III or higher
  • Coagulopathy, local infection, or contraindication to spinal anesthesia
  • Body mass index greater than 35 kg/m²
  • Pregnancy or impaired consciousness
  • Intraoperative hemodynamic instability or anticipated instability
  • Need for additional intraoperative sedative or analgesic medication
  • Inability to obtain adequate and reliable NIRS signal for technical reasons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cemil Tasciogu Research and Training Hospital

Istanbul, Sisli, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident doctor

Study Record Dates

First Submitted

March 11, 2026

First Posted

March 16, 2026

Study Start

March 25, 2025

Primary Completion

September 12, 2025

Study Completion

December 25, 2025

Last Updated

May 28, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because no formal data-sharing plan was established for this thesis-based observational study, and sharing is limited by institutional and ethics requirements.

Locations